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Abstract The objective of this study was to investigate the
antimicrobial resistance, Tn1546 transposon variability and
plasmid diversity among Polish vancomycin-resistant
Enterococcus faecium (VREfm) isolates of VanA phenotype
in the context of their clonal structure. Two hundred sixteen
clinical VREfm isolates collected between 1997 and 2010
were studied by antimicrobial susceptibility testing, MLST,
MLVA and detection of IS16, espEfm, pilA, intA and
plasmid-specific genes by PCR. Tn1546 structure was re-
vealed by overlapping PCR and sequencing. Selected isolates
were subjected to PFGE-S1 and Southern hybridization anal-
yses. The vast majority of the isolates (95.8 %) belonged to
lineages 17/18 (during the whole study period 1997–2010)
and 78 (mostly in 2006–2010) of hospital-adapted meroclone
of E. faecium. All isolates displayed a multi-drug resistance
phenotype. Twenty-eight Tn1546 types (including 26 novel
ones) were associated with eight different ISs (IS1216,
IS1251, ISEfa4, ISEfa5, ISEfm2, ISEf1, IS3-like, ISEfm1-
like). The vanA-determinant was typically located on plas-
mids, which most commonly carried rep2pRE25, rep17pRUM,
rep18pEF418, rep1pIP501, ω-ε-ζ and axe-txe genes. VanA iso-
lates from 1997–2005 to 2006–2010 differed in clonal com-
position, prevalence of gentamicin- and tetracycline-
resistance and plasmidome. Our analysis revealed high com-
plexity of Tn1546-type transposons and vanA-plasmids, and
suggested that diverse genetic events, such as conjugation
transfer, recombination, chromosomal integration and DNA
mutations shaped the structure of these elements among
Polish VREfm.
Introduction
In the past 20 years, vancomycin-resistant enterococci
(VRE) have emerged as nosocomial pathogens world-
wide. In Poland, the first VRE outbreak due to
Enterococcus faecium (VREfm) of VanA phenotype
started in December 1996 in the Gdańsk Medical
University [1]. The vast majority of VREfm observed
worldwide belongs to a specific hospital meroclone, ini-
tially described as clonal complex 17 (CC17), later di-
vided into three distinct lineages 17, 18 and 78 based
on multilocus sequence typing (MLST) analyses [2, 3].
Recently, the approach called Bayesian Analysis of
Population Structure (BAPS), applied to the E. faecium
MLST data delimited two groups within the hospital
meroclone, 2–1 and 3–3, corresponding to lineages 78
and 17/18, respectively [4]. Strains belonging to the
hospital meroclone are ciprofloxacin- and ampicillin-re-
sistant, enriched in putative virulence traits, and show a
distinct genetic repertoire, including cell surface protein
genes (fms), regulatory genes, putative pathogenicity
islands, plasmids, insertion sequences (IS) and integrat-
ed phages, which promote their adaptation [5–7]. The
presence of IS16 and the E. faecium-specific esp gene
(espEfm), carried on the integrative conjugative element
ICEEfm1, together with the intA integrase gene, are
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proven molecular markers of hospital-associated
E. faecium [8–10].
Several glycopeptide-resistance phenotypes have been de-
scribed so far, with VanA and VanB being the most common
in enterococci isolated from hospital infections [11]. The vanA
gene cluster is carried on Tn1546-type transposons [12],
which show a significant degree of heterogeneity, associated
with presence of point mutations, deletions and presence of
various ISs [13, 14]. A few studies demonstrated the location
of Tn1546 on Inc18, pRUM-like, pMG1-like, and pLG1 plas-
mids [15, 16]; however, the knowledge of vanA-plasmids and
their epidemiology is still far from being satisfactory and may
differ significantly among countries.
In Poland, hospital VRE isolates are continuously submit-
ted for confirmation and further analyses to the National
Reference Centre for Susceptibility Testing (NRCST), located
at the National Medicines Institute in Warsaw. The aim of this
study was to characterize E. faecium VanA isolates collected
by the NRCST since 1997 until the end of 2010, focusing on
the Tn1546 transposon variability and vanA-plasmid diversity
in the context of the clonal structure of VREfm isolates to
provide the country-wide picture of these important hospital
pathogens.
Materials and methods
Bacterial isolates and susceptibility testing
The study comprised 216 consecutive, non-repetitive (1
isolate per patient) VREfm VanA isolates received by
the NRCST from 42 hospitals in 24 cities in Poland
over the period 1997–2010. Part of the isolates analyzed
in this work correspond to strains partially tested in
previous surveillance studies, including: 108 VanA rep-
resentatives of the VREfm collection from 1997 to 2005
[17] and 20 representative isolates of a E. faecium
VanA outbreak in 2009 [18]. The majority of isolates
(n = 137) were derived from 11 VanA outbreaks and the
remaining 79 isolates were reported as single isolations.
Of the 216 isolates, 211 (97.7 %) were from hospital-
ized patients and five (2.3 %) were from the hospital
environment. Among the isolates from hospitalized pa-
tients, a total of 37 isolates (17.5 %) were from inva-
sive infections (31 isolates from blood and 6 from other
sources); 52 isolates (24.6 %) were from non-invasive
infections (21 from urine, 18 from wounds, and 13 from
other sources) and 122 (57.8 %) represented faecal car-
riage. Antimicrobial susceptibility of 88 isolates, not
investigated previously, was tested by the Etest method
(bioMérieux, Marcy l’Etoile, France) for daptomycin,
t e i cop l an in and vancomyc in and by a b ro th
microdilution method [19] for the remaining compounds
(Table 1). Multidrug-resistant (MDR) isolates were de-
fined as recommended [20]. Vancomycin-resistance de-
terminants were detected by PCR as described previous-
ly [21] with the E. faecium BM4147 and E. faecalis
V583 strains as positive vanA and vanB controls,
respectively.
DNA isolation and genotyping of isolates
Total DNA of isolates was extracted using Genomic DNA
Prep Plus kit (A&A Biotechnology, Gdansk, Poland).
Multilocus VNTR analysis (MLVA), MLST, and detection
of 19 rep families and the unique reppMG1 gene were per-
formed as described [22–24]. Sequence types (STs) were
grouped to CCs by the comparative eBURST analysis per-
formed against the whole E. faecium MLST database. PCR
detection of IS16, espEfm, fms21 (pilA), reppLG1, plasmid ad-
diction systems, relaxase genes, and intAICEEfm1 was per-
formed as described (Supplementary Table 1 and references
therein). DNA of enterococcal isolates from our laboratory
collection [17, 18, 25] served as positive controls.
Plasmid profiling, hybridization analyses, Tn1546 typing
and statistical analysis
DNA in agarose plugs was obtained as described [21], treated
with S1 nuclease (Takara Bio, Japan) and separated by PFGE
with Lambda Ladder PFG marker (New England Biolabs,
Beverly, MA) [26] followed by blotting onto the Hybond
membrane (GE Healthcare, Buckinghamshire, UK) by capil-
lary transfer. Hybridization was carried out using the
Amersham ECL Random-Prime Labelling and Detection
System (GE Healthcare, Buckinghamshire, UK). Tn1546
transposon was investigated by PCRmapping and sequencing
(Supplementary Table 1 and references therein) of selected
regions encompassing 7571 bp out of 10851 bp (i.e., ∼70 %
of the transposon, Fig. 1). The Tn1546 sequence of E. faecium
BM4147 (GenBank acc. no.: M97297) [12] was used as a
reference. The nomenclature of Tn1546-type transposons in
the present study was based on the following alphanumeric
code: the ‘A’ types (A1-A6) referred to transposon variants of
the wild type (wt) Tn1546 structure (A1) not interrupted by
insertion sequences; the ‘B’ types contained 1–3 copies of
IS1216 (B, BB, BBB types); the C, D, E, F, G, H and I types
carried IS1251, ISEfa5, ISEfa4, ISEfm2, ISEf1, ISEfm1-like
and IS3-like elements, respectively. Transposons with more
than one IS type were described by a two-, three- or four-
letter code (e.g., ‘BC’ with both IS1216 and IS1251). The
Arabic numerals indicated differences in the presence of par-
ticular point mutations as well as the orientation of ISs and the
localization of their insertion sites (e.g., B1-B4). The novel
ISEfm1-like sequence was submitted to GenBank
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(KT719407). Chi-square test was used to assess the differ-
ences of distributions, with p ≤ 0.05 considered significant.
Results
Susceptibility to antimicrobial agents
All isolates were resistant to vancomycin and teicoplanin
(Table 1) and carried vanA. Resistance to ampicillin, cipro-
floxacin, tetracycline, chloramphenicol, gentamicin and strep-
tomycin (high level) was prevalent or highly prevalent and all
isolates showed the MDR phenotype. A significant decline in
the prevalence of both tetracycline-resistance (from 68.9 to
52.3 %, p = 0.01) and high-level gentamicin resistance (from
92.1 to 64.4 %, p < 0.0001) was found between the 1995–
2005 and 2006–2010 periods. A single isolate was resistant
to linezolid and two isolates to quinupristin/dalfopristin. All
isolates were susceptible to tigecycline and daptomycin.
MLVA, MLST, IS16 and virulence markers detection
MLVAwas performed for 196 isolates and these results were
analysed together with data obtained earlier for 20 isolates from
the 2009 outbreak [18]. Among 216 isolates, 37 different
MLVA types (MTs) and three incomplete profiles (due to lack
of VNTR7 amplification) were observed, that included 207 and
nine isolates, respectively (Supplementary Table 2). MT1,
MT159, MT25 and MT13 were most prevalent, with 36, 34,
26 and 20 isolates, respectively. All MT159 isolates except one
were isolated in 2006–2010 (p ≤ 0.0001), in contrast to isolates
of MT25, which all except one were isolated in 1997–2005
(p = 0.0001). The MT1 isolates showed a similar frequency
over the whole study period (13.2 % vs 21.6 %, p = 0.07). In
the present study, STs and the presence of IS16, espEfm, intA
and pilAwere determined for 88 isolates not encompassed by
the previous studies (i.e., 68 isolates from 2006 to 2010 and 20
isolates from 2001 to 2002), and these results were analysed
with the data obtained previously for the remaining 128 iso-
lates. Altogether, 40 different STs were found, with 18 STs
(45.0 %) represented by single isolates. The vast majority of
the STs, i.e. 36 STs representing 207 isolates (95.8 %),
belonged to the hospital-adapted meroclone of E. faecium; lin-
eage 17/18 included 31 STs with 165 isolates and was present
during the whole period 1997–2010, while lineage 78 included
five STs characteristic for 42 isolates, occurring mostly in
2006–2010 (p ≤ 0.0001). IS16 was present in 207 (95.8 %)
isolates and 186 (86.1 %) isolates harboured the espEfm gene.
The integrase gene intA and the pilA gene were found in 181
(83.8 %) and 214 (99.1 %) isolates, respectively.























S ≤ R >
Vancomycina 216 (100) 128 (100) 512 >512 88 (100) >256 >256 4 4
Teicoplanina 216 (100) 128 (100) 64 128 88 (100) 48 >256 2 2
Ampicillina 215 (99.5) 128 (100) >128 >256 87 (98.8) 128 >256 4 8
HLGRa 172 (79.6) 118 (92.2) >1024 >1024 54 (64.4) >1024 >1024 128 128
HLSRa 167 (77.3) 112 (87.5) >1024 >2048 55 (62.5) >1024 >2048 512 512
HLAR 28 147 (68.1) 110 (86) >1024 >1024 37 (42) >1024 >2048 - -
Quinupristin/
dalfopristina
2 (0.9) 1 (0.8) 1 2 1 (1.1) 1 1.5 1 4
Linezolida 1 (0.5) 0 (0) 1 4 1 (1.1) 1 2 4 4
Tigecyklinea 0 (0) 0 (0) 0.06 0.19 0 (0) 0.06 0.25 0.25 0.5
Tetracyclineb 135 (62.2) 89 (68.9) 64 128 46 (52.3) 8 128 4 4
Ciprofloxacinb 215 (99.5) 127 (99.2) 128 >256 88 (100) 128 256 4 4
Daptomycinb 0 (0) 0 (0) 2 3 0 (0) 2 3 4 4
Chloramphenicolc 53 (24.4) 30 (23.2) 8 16 23(26.1) 8 16 8 ≥32c
MDR28 216 (100) 128 (100) nc nc 88 (100) nc nc – –
nc not calculated, n number of isolates
The results were interpreted following the European Committee on Antimicrobial Susceptibility Testing (EUCAST)-approved breakpoints [53] and the
Ecological Cut-Off (ECOFF) values for compounds without defined breakpoints (http://mic.eucast.org/Eucast2/, last accessed 20th July 2015). For
chloramphenicol the Clinical and Laboratory Standards Institute (CLSI) breakpoints were used [19]a Interpretation according to the EUCAST clinical
breakpoint valueb Interpretation according to the EUCAST Ecological Cut-off (ECOFF) valuec Interpretation according to CLSI breakpoint value
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1 2 3 4 5 6 7 8 9 10 10,851 kb
Fig. 1 Diversity of Tn1546 transposon types among E. faecium VanA
isolates. Position of primers used in PCR mapping and sequencing
indicated by arrows with primer names; open rectangles, transposon
genes; stars, positions of point mutations; analyzed areas of the
transposon shadowed; dashed lines, deletions in the left arm of the
transposon; filled rectangles, deletions within the transposon; vertical
arrow, triangles with arrows, the IS positions; single-nucleotide insertion
in vanY
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Structural diversity of Tn1546 transposons
The structure of Tn1546-type transposons was determined
for 187 isolates while for 20 isolates the structure of the
transposon (representing types A1 and G, Fig. 1) had been
published earlier [18]. In the case of nine isolates the
structure of the transposon could not be determined in
spite of repeated attempts due to lack of PCR products
for some parts of the transposon, which might have been
caused by sequence polymorphism(s) within PCR primers
annealing sites, and discrepancies of sequencing results in
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more than one transposon in a single isolate. Twenty-eight
transposon types, including 26 new ones, were discerned
in the analyzed group (Fig. 1). The most predominant
types, including C1 (40 isolates), B2 (n = 38), A3 (n =
36), G (n = 25), E (n = 14), A1 (n = 13) and D (n = 7),
were associated with several STs and typically showed a
multicenter distribution. Eight different ISs were detected
within Tn1546, including IS1216, IS1251, ISEfa4,
ISEfa5, ISEfm2, ISEf1, IS3-like and ISEfm1-like. The
most common IS1216 was present in all 16 B-type trans-
posons, both in the direct and reversed orientations, with
five different types of 8-bp direct repeats. These B-type
transposons were found in Gdańsk and Warsaw, as well as
in 14 other cities. IS1251 was associated with seven
Tn1546 types (C1-C2, BC1-BC5) and present in 53 iso-
lates (25.6 %), which mainly originated from Kraków and
Warsaw. In these isolates, IS1251 was always inserted in
the vanS-vanH intergenic region of the transposon at the
position 5813. The D, E, F and G types of transposon
were characterized by the presence of ISEfa5, ISEfa4,
ISEfm2 and ISEf1 in the vanX-vanY intergenic region,
respectively. These types were generally limited to one
or two centres, with the exception of the G type, which
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occurred in seven other centres. An insertion of an IS in
98 % identical to ISEfm1 (GenBank no. AF138282) in the
vanX-vanY intergenic region resulted in the BH-type of
transposon.
The variability of Tn1546 was additionally associated
with the presence of deletions, insertions and point mu-
tations. In the A4 type, a 44 nt deletion in the vanS-
vanH intergenic region (nt 5896–5939) was observed.
Other deletions, located in orf2, vanX and the vanX-
vanY intergenic region coincided with the presence of
ISs (six types: BB1, BB2, BC4, BC5, BBI, BBBI2).
Seven different point mutations were detected, including
four known previously (T7658C, G7747T, G8234T,
C9692T) [18, 27, 28] and three new ones (G5603A,
A8138G and G9063T). The G5603A mutation resulted
in the A80T change in VanS and the G9063T mutation
in the L4F change in VanY. The B4 type, found in two
independent isolates, demonstrated the presence of a
novel single-nucleotide T insertion between nt 9063–
9064 within the vanY gene, resulting in translational
frameshift and a truncated VanY. Nevertheless, these
two isolates showed high MIC values for vancomycin
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Plasmid gene content among VREfm and diversity
of vanA-plasmids
PCR-based typing of plasmid replication initiator genes (rep)
was performed for 196 isolates and these results were com-
bined with the data for 20 isolates, published previously [18].
Altogether, ten rep-types were observed among VREfm-VanA
(Fig. 2). Isolates carried from one up to seven different rep
genes, with 4.7 rep genes per isolate on average. Isolates pos-
itive for rep1pIP501, rep7pT181 and reppMG1 appeared mainly in
the period 1997–2005, while rep11pEF1071 gene was typical
for isolates obtained in 2006–2010. The plasmid stabilization
systems axe-txe and rep17pRUM were present in the majority
of isolates. Another system, ω-ε-ζ, was also quite common,
predominantly among rep2pRE25-carrying strains, and oc-
curred mainly in the period of 2006–2010. Two additional
systems, mazEF and relBE, were observed only in 2003 for
six and two isolates, respectively. The relpCIZ2 and relpEF1
relaxase genes were prevalent, and additionally relpHTß and
relpRE25 were detected. The majority of relpRE25-positive iso-
lates (n = 22, 91.7 %) were also rep2pRE25-positive, however,
most of 169 rep2pRE25-positive isolates lacked this relaxase.
Isolates carrying relpHTß dominated in 1997–2005 (40 out of
45 relpHTß-positive isolates) and the majority of relpHTß -
positive isolates also harboured reppMG1 (n = 43, 95.5 %).
Fifty-two isolates, obtained from 24 medical centres over
the whole study period and representing 26 different STs and
21 Tn1546 types were selected for PFGE of S1-digested DNA
and hybridization analyses. Additionally, the results obtained
previously for three isolates from the 2009 outbreak [18] were
included for comparative purposes. Investigated isolates
showed the presence from one up to 11 plasmid bands per
isolate in PFGE-S1 analyses. Subsequent hybridization with
the vanA probe revealed the presence of 86 vanA-plasmids
with up to four such plasmids in an isolate, and two cases of
chromosomal localization of vanA (Table 2). Further hybridi-
zation studies showed the co-localization of vanA determi-
nants with all six tested rep types, including rep2pRE25,
rep17pRUM, rep18pEF418, rep1pIP501, reppLG1 and reppMG1 that
accounted for 40.7 % (n = 35), 40.7 % (n = 35), 24.4 % (n =
21), 19.8 % (n = 17), 5.8 % (n = 5) and 1.2 % (n = 1) of vanA-
plasmids, respectively. The vanA-plasmids with rep1pIP501
were limited to isolates from 1997 to 2005, circulating in
two hospitals in Poznań. These plasmids differed by size
(from ca. 30 to ca. 265 kb) and presence of other rep and
toxin-antitoxin genes, and carried four different types of
Tn1546, with A3 being predominant (8 out of 13 isolates
harbouring vanA-plasmids with rep1p IP501) . The
vanA-plasmids with rep2pRE25, rep17pRUM and rep18pEF418
genes showed a multicentre distribution and occurred during
the whole study period. In total, 37 (43 %) vanA-plasmids
were associated with more than a single rep type and 21
vanA-plasmids (24.4 %), present in 11 isolates, did not hybrid-
ize with any of the tested rep genes. With a single exception,
these latter plasmids were obtained during 2006–2010 (p =
0.001). Five of the isolates with these unknown replicons con-
comitantly carried three vanA-plasmids, ca. 30, 160 and
380 kb in size, which did not hybridize with any probes of
toxin-antitoxin and relaxase genes tested. All these isolates
carried B2 transposons, but belonged to diverse STs and
MTs, and originated from four different medical centres over





















































Fig. 2 Plasmid-associated gene distribution among Polish VREfm VanA. Number of isolates with a particular gene given above the graph bars
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were commonly carried by vanA-plasmids (35 and 32 plas-
mids, respectively). The ω-ε-ζ system was characteristic for
rep2pRE25 plasmids and axe-txe for rep17pRUM plasmids (71.4
and 62.9 % of the respective vanA-plasmids). The gene spec-
ifying pEF1-relaxase was located on 11 vanA-plasmids
(12.8 %), with various rep types. Some of the presumed ge-
netic events, that could be inferred on the basis of these anal-
yses, include examples of transposon evolution within an en-
terococcal strain, Tn1546 transposition among plasmids,
conjugative transfer of plasmids, and their changes such as
recombination or chromosomal integration as proposed in
Table 2.
Discussion
Currently, VREfm play an increasingly important role in nos-
ocomial infections and are considered alert pathogens [29],
with vanA as a main determinant of this phenotype within
many countries [30]. In Poland VRE remain less prevalent
than in the United States or some European countries, e.g.
our recent study revealed 7 % vancomycin-resistance among
invasive E. faecium collected during 2010–2011 [31].
Although we observed an increasing prevalence of VanB
E. faecium [17], VanA is still most frequent among Polish
VREfm ([31] and NRCST unpublished observations). In the
present study we aimed at the characterization of clonality of
VanA-VREfm and genetic elements associated with this resis-
tance determinant. Numerous reports show that in the case of
human nosocomial infections vancomycin resistance is almost
exclusively acquired by the hospital-adapted meroclone of
E. faecium, now widespread all over the world [2, 3] and
prevalent among invasive E. faecium in Polish hospitals
[31]. In this study, the vanA determinant was carried by rep-
resentatives of this meroclone with only a few exceptions
limited to the 1997–2005 period. These isolates might repre-
sent intermediates, by which glycopeptides resistance deter-
minants were introduced into hospitals. All isolates belonging
to hospital meroclone, as expected, were resistant to both am-
picillin and ciprofloxacin, and enriched in putative virulence
traits / markers such as IS16, espEfm, intAEfm and pili genes.
The population structure determined for Polish VREfm VanA
closely resembled these of hospital-associated E. faecium in
other countries. High diversity of STs/MTs is consistent with
the presence of polyclonal hospital population of E. faecium
that subsequently acquires vancomycin resistance determi-
nants [13, 14]. The vast majority of isolates grouped into hos-
pital lineage 17/18, mostly represented by STs 17, 117, 18,
132, 202 and lineage 78, which included STs 78, 192 and 412.
In contrast to several other countries, where ST203 and ST16
constituted a significant proportion of hospital E. faecium [3,
14, 32, 33], in our population only one representative of ST16
was found and ST203 was completely absent. The
characteristic change in the proportion of isolates belonging
to lineage 17/18 and lineage 78 was observed since the year
2005when lineage 78 started to be significantly more frequent
in Poland. Our results are in agreement with observations
made in other studies, suggesting waves of successful
E. faecium, first from lineage 17/18 and followed by lineage
78 strains [4, 34]. This population shift, apparent inMLSTand
MLVA, was additionally associated with a change in
plasmidome composition and observed decreased resistance
levels to tetracycline and aminoglycosides.
Diversity of Tn1546 in VREfm is typical for this transpo-
son, as reported by others [13, 14]. Nevertheless, in the present
study we observed several new variants of Tn1546. VanA
transposons indistinguishable from the Tn1546 A1 prototype
[12] were frequently encountered in Europe, especially in the
late 1990s and 2000s [14, 27]. This type and its mutational
derivatives (A2-A6) were ubiquitous among early VREfm in
our study. Single-nucleotide T insertion between nt 9063–
9064 in the vanY gene of B4 type of transposon resulted in a
translational frameshift and a truncated translation product.
This change, however, did not abolish the glycopeptide resis-
tance. VanY is a membrane-associated D,D-carboxypeptidase
that hydrolyses the C-terminal D-Ala or D-Lac residue of
peptidoglycan precursors but lacks transpeptidase activity.
VanY, together with VanZ, represent accessory proteins,
which are not required for the expression of glycopeptide
resistance but increase its level [35]. Isolates with a deletion
of vanY gene showed lower resistance levels to teicoplanin,
likely due to the diminished transcription of vanZ while point
mutations in vanY, observed so far were not associated with a
loss of protein function [27, 36].
Activity of various ISs represented a very important
factor, contributing to the formation of several novel
transposon types. IS1216, the most common IS in our
study, characteristic for B-types, was detected at various
positions of the transposon, and its insertion often resulted
in deletions of adjacent sequences in ORF2, vanX and the
vanX-vanY intergenic region, as observed by others [13,
27]. The BI, BBI, BBBI types, apart from IS1216, exhib-
ited the concomitant presence of a IS1216V-IS3-like ele-
ment, originally reported in 1995 [37]. Since then, this
element was described in several studies, which reported
intact as well as a 5′-truncated IS3-like sequence [27, 38],
both of which were also detected in our study. The C-
type, harbouring IS1251, was relatively frequent and the
integration sites of this IS were identical to those pub-
lished by others [14, 37, 39]. Sequencing analysis allowed
discerning the C1-type, specific for Krakow hospitals and
the C2-type, found in other cities. The D type transposon,
containing ISEfa5, to our knowledge, represents the first
example of this variant outside of South America [34].
Type E represents the first insertion of ISEfa4 in the
vanX-vanY intergenic region. This IS was described
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earlier in orf2-vanR and vanS-vanR intergenic regions [40,
41], as well as within IS1542 [42]. The F type harboured
ISEfm2, representative of the IS256 family. Thus far, in
enterococci this IS has been solely observed inserted be-
tween orf13 and tetS within CTn6000 transposon [43]. In
our study, we report for the first time the insertion of
ISEfm2 into Tn1546. The G type transposon with ISEf1,
reported earlier for the VREfm outbreak in two
neighbouring Warsaw medical centres in 2009 [18] was
additionally detected in isolates from 2009 to 2010 de-
rived from seven different cities, which may indicate its
multicenter spread. Integration of the ISEfm1-like element,
belonging to the IS982 family in the BH type, represents yet
another novel insertion event in Tn1546. The presence of
ISEfm1 was described previously in the vanX-vanY intergenic
region [44], as well as within the vanD operon [45]. Complex
analysis of transposon structures described in our study
revealed the potential scheme of their hypothetical evolution
among Polish VREfm. In this scenario, we propose the A1 type
as presumable ancestor variant, with remaining types being its
direct or indirect derivatives (Fig. 3).
The vanA determinants are almost exclusively located
on plasmids and these elements play a very important
role in the spread of glycopeptides resistance [46]. Our
results show that the Polish VREfm population is
enriched in plasmid replicons of different families in-
cluding megaplasmids, Inc18-, pRUM- and pMG1/
pHT-like plasmids, encountered in VanA-VREfm in oth-
e r coun t r i e s [16 , 46 , 47 ] . S i ze va r i a t i on o f
vanA-plasmids, even within the same family indicates
their flexibility, and identification of multiple rep types
in a single plasmid suggests a common presence of
plasmid cointegrates. We observed an interesting change
in the VanA-associated plasmidome between early
(1997–2005) and more recent (2006–2010) isolates. In
particular, rep1-vanA replicons were quite abundant
among early isolates and typically located on plasmids
over 140 bp in size. Together with rep2-vanA replicons they
represent the Inc18 family, associated with Tn1546 elements
among clinical E. faecium in Europe [16, 47]. Another shift in
plasmidome composition between early and recent isolates
was shown for pMG1 replicons, present exclusively among
early VREfm. High prevalence of pMG1-like elements was
observed among VREfm in the United States and Japan, where
they contributed to the spread of both aminoglycoside and






































Fig. 3 Hypothetical evolution of Tn1546 structures among Polish
VREfm VanA. Type A1, found in different cities, is a presumable
ancestor variant with remaining types being its direct or indirect
derivatives. Types A2, A3 and A5 developed by point mutations in wt
type. A4 developed from A3 through single deletion events in the vanS-
vanH intergenic region. A6 is an A3 derivative that lacks ca. 1900 bps in
the 5′ end. The E type transposon, a third potential derivative of A3, arose
through acquisition of ISEfa4 between vanX and vanY. A3 and its
derivatives were typical for Poznań (Po) medical centres. B3 and G var-
iants presumably developed from A5 after insertion events of IS1216 and
ISEf within vanX-vanY intergenic region in Kraków (Kr) and Warsaw
(Wa), respectively. The ubiquitous B2 type, typical for Warsaw, probably
emerged from a single insertion event of IS1216within the A1 typewith a
concomitant deletion of the 5′ end of the transposon. The B4 (additional
single nucleotide insertion within vanY) and BH (ISEfm1-like insertion
between vanX and vanY) types represent possible derivatives of B2. The
B1, D and F transposon types are potential derivatives of A1 formed by
IS1216, ISEfa5 and ISEfm2 insertions, respectively. Another group of
transposon variants, encompassing types BI, BBI, BBBI1, BBBI2, BB1
and BB2 emerged through complex insertion and deletion events in dif-
ferent regions of wt transposon promoted mostly by IS1216 elements.
This group was detected mainly in Gdańsk (Gd). The activity of another
insertion sequence, IS1251, followed by IS1216 insertions and several
point mutations resulted in the formation of C- and BC-types in Kraków
and Warsaw, respectively
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pRUM derivatives constitute the second main carrier of van-
comycin resistance among the contemporary E. faecium iso-
lates [16, 46]. Plasmids with the pRUM-like rep can be divided
into two groups, one with axe-txe genes and mob regions from
the staphylococcal pC223 plasmid and the other with relaxase
from pEF1 and lacking axe-txe [15, 16, 46]. Our results indi-
cate that representatives of both these groups are present
among Polish VREfm. Additionally, we observed plasmids
with unknown rep types among isolates obtained since 2006,
which suggests the appearance of a new vanA-plasmid type(s),
not included in the available classification scheme [24] and
which will be a subject to further studies.
Finally, the analysis of PFGE-S1 hybridization results
in the context of epidemiological information, determined
Tn1546 types and the clonal background of the isolates,
which revealed a high complexity of genetic events in-
volving VREfm with VanA phenotype and resulting in
the dissemination of this type of resistance. As these 52
isolates were pre-selected for a maximal representation of
the collection diversity, only a few examples of clonal
spread were observed, such as dissemination of ST132
strain with a 45-kb plasmid harbouring C1 transposon in
a Krakow hospital (Table 2). The role of VREfm clonal
spread in Poland, however, had been demonstrated before
in our outbreak studies [18, 39, 48]. Particular types of
transposons in the analysed group were frequently associ-
ated with various plasmid vectors. This situation may
have resulted from transposition of Tn1546 among plas-
mids [12], promoted by integration ‘hot-spots’ [49] and
from the recombination processes among enterococcal
plasmids [15, 50]. The present study also provided exam-
ples of involvement of plasmids as vectors of vancomycin
resistance, by demonstrating the presence of plasmids of
the same size and with the same transposon types and
plasmid-specific genes in different strains, as found in
other studies [15, 51]. Occasionally, vanA-plasmids ap-
peared to be integrated into bacterial chromosome, in
agreement with other observations [52]. Further detailed
studies employing extensive sequencing are indispensable
to fully elucidate the events involving genetic elements
engaged in the dissemination of the vanA gene cluster in
the population of Polish VREfm.
In conclusion, the VREfm of the VanA phenotype collected
in our country over the period 1997–2010 represent a highly
variable group in the respect of their clonal composition, plas-
mid content and structures of Tn1546, a direct carrier of vanA
genes. High genetic plasticity of these organisms, together
with a rapid global spread of successful hospital-adapted en-
terococcal clones constitute a significant and continuously
increasing epidemiological threat for human health. Thus,
both epidemiological situation concerning VREfm as well as
genetic elements and strains associated with VanA vancomy-
cin resistance warrant further studies.
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